Outcomes of laparoscopic fertility-sparing surgery in clinically XXXX .

@entity1 @entity43
OBJECTIVE: Fertility-sparing surgery (FSS) is becoming an important technique in the surgical management of young @entity1 with @entity43 ( @entity43 ). We retrospectively evaluated the outcome of laparoscopic FSS in presumed clinically early-stage @entity43 . METHODS: We retrospectively searched databases of @entity1 who received laparoscopic FSS for @entity43 between January 1999 and December 2012 at Samsung Medical Center. @entity1 aged  <=40 years were included. The perioperative, oncological, and obstetric outcomes of these @entity1 were evaluated. RESULTS: A total of 18 @entity1 was evaluated. The median age of the @entity1 was 33.5 years (range, 14 to 40 years). The number of @entity1 with clinically stage IA and IC was 6 (33.3%) and 12 (66.7%), respectively. There were 7 (38.9%), 5 (27.8%), 3 (16.7%), and 3 @entity1 (16.7%) with mucinous, endometrioid, clear cell, and serous tumor types, respectively. Complete surgical staging to preserve the uterus and one ovary with adnexa was performed in 4 @entity1 (22.2%). Two out of them were upstaged to The International Federation of Gynecology and Obstetrics stage IIIA1. During the median follow-up of 47.3 months (range, 11.5 to 195.3 months), there were no perioperative or long term surgical complications. Four @entity1 (22.2%) conceived after their respective @entity43 treatments. Three (16.7%) of them completed full-term delivery and one is expecting a baby. One @entity1 had disease recurrence. No @entity1 died of the disease. CONCLUSION: FSS in young @entity1 with presumed clinically early-stage @entity43 is a challenging and cautious procedure. Further studies are urgent to determine the safety and feasibility of laparoscopic FSS in young @entity1 with presumed clinically early-stage @entity43 .
